- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06843395
ACT-based EMI in College Students
March 6, 2025 updated by: The Hong Kong Polytechnic University
Assessing the Feasibility, Acceptability and Effectiveness of an Transdiagnostic Acceptance and Commitment Therapy-based Ecological Momentary Intervention in College Students: a Pilot Randomized Controlled Trial
This study aims to evaluate the acceptability and effectiveness of a transdiagnostic, Acceptance and Commitment Therapy (ACT)-based ecological momentary intervention (EMI) among college students.
A mixed-methods pilot randomized controlled trial (RCT) will be conducted to assess its impact on psychological flexibility, well-being and mental health outcomes.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Detailed Description
Mental health issues are prevalent among college students, yet traditional interventions often face barriers related to accessibility and engagement.
This study explores the feasibility, acceptability, and preliminary effectiveness of a transdiagnostic ACT-based EMI designed to deliver in-the-moment psychological support via digital platforms.
A mixed-methods pilot RCT will be conducted, with participants randomly assigned to either the ACT-based EMI group or a mood monitoring group.
Quantitative measures will assess changes in psychological flexibility, stress, anxiety, depression, and well-being, while qualitative interviews will provide insights into user experience, engagement, and perceived benefits or barriers.
Findings from this study will inform the optimization of ACT-based digital interventions for college students and contribute to the growing field of personalized, technology-assisted mental health care.
Study Type
Interventional
Enrollment (Estimated)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Tao Zhang
- Phone Number: +85294233827
- Email: tao-t.zhang@connect.polyu.hk
Study Locations
-
-
-
Hong Kong, China
- The Hong Kong Polytechnic University
-
Contact:
- Bryant HUI
- Phone Number: +852 2766 7744
- Email: phhui@polyu.edu.hk
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Participants in our study are healthy college students
- have smartphone, and have access to the internet
Exclusion Criteria:
- currently participating in another research
- have significant cognitive impairment that prevents participation in the research
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: N/A
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Placebo Comparator: Mood monitoring condition
Only pre- and post-assessments and ecological momentary assessment (EMA) measurements are conducted.
|
Participants do not receive any intervention.
During the intervention period, they only need to complete ecological momentary assessments twice a day.
|
|
Experimental: ACT-based EMI group
Participants are required to complete a 7-day ecological momentary intervention (EMI).
|
The intervention is based on Acceptance and Commitment Therapy (ACT) and includes the six core processes (being present, acceptance, defusion, self-as-content, values, and taking action).
It is delivered in the form of an ecological momentary intervention (EMI), lasting for 7 days with two sessions per day.
The intervention aims to enhance mental health, well-being, and psychological flexibility.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Mental well-being
Time Frame: Baseline (pre-intervention); Immediately after the intervention (1 week after baseline); 1-month follow-up (1 month after intervention)
|
The 14-item Mental Health Continuum-Short Form (MHC-SF) will be used to measure mental well-being during the past month.
This scale has 3 dimensions: emotional well-being (EWB), psychological well-being (PWB), and social well-being (SWB).
Each item is rated on a 6-point scale from 0 (never) to 5 (every day), with a higher score indicating greater well-being.
|
Baseline (pre-intervention); Immediately after the intervention (1 week after baseline); 1-month follow-up (1 month after intervention)
|
|
Psychological distress
Time Frame: Baseline (pre-intervention); Immediately after the intervention (1 week after baseline); 1-month follow-up (1 month after intervention)
|
Psychological distress will be measured using the 21-item Depression Anxiety Stress Scale.
They ask about depressive symptoms, anxiety symptoms, and general stress symptoms.
Each item is rated on a 4-point Likert scale from 0 (did not apply to me at all) to 3 (applied to me very much or most of the time).
Higher scores indicate more psychological distress
|
Baseline (pre-intervention); Immediately after the intervention (1 week after baseline); 1-month follow-up (1 month after intervention)
|
|
Acceptability
Time Frame: post-intervention (one week after baseline)
|
The 8-item Client Satisfaction Questionnaire (CSQ-8) is employed to measure client satisfaction.
Each item is rated on a 4-point Likert scale.
Higher scores reflect better client satisfaction.
|
post-intervention (one week after baseline)
|
|
Overall mental health
Time Frame: Baseline (pre-intervention); Immediately after the intervention (1 week after baseline); 1-month follow-up (1 month after intervention)
|
Overall mental health will be measured using the 12-item General Health Questionnaire (GHQ-12).
Each item is rated on a 4-point Likert scale, with total scores ranging from 0 to 36.
Higher scores indicate greater mental health difficulty.
|
Baseline (pre-intervention); Immediately after the intervention (1 week after baseline); 1-month follow-up (1 month after intervention)
|
|
Psychological flexibility and inflexibility
Time Frame: Baseline (pre-intervention); Immediately after the intervention (1 week after baseline); 1-month follow-up (1 month after intervention)
|
The multidimensional psychological flexibility inventory short form (MPFI-24) is a 24-item scale assessing psychological flexibility.
The scale consists of a flexibility subscale and an inflexibility subscale, divided into 12 dimensions, with 2 entries for each dimension, a total of 24 entries, and scored at levels 1 (never true) to 6 (always true).
|
Baseline (pre-intervention); Immediately after the intervention (1 week after baseline); 1-month follow-up (1 month after intervention)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
State affect
Time Frame: During the 7-day intervention period, measurements are conducted twice per day.
|
State affect will be tapped by the 9-item Emmons Mood Indicator.
Participants indicate their momentary feelings on a 7-point Likert scale ranging from 1 (not at all) to 7 (extremely), for NA (e.g., depressed, worried/anxious, and unhappy) and PA (e.g., joyful, happy, and enjoyment/fun).
|
During the 7-day intervention period, measurements are conducted twice per day.
|
|
State anxiety and depression
Time Frame: During the 7-day intervention period, measurements are conducted twice per day.
|
State anxiety and depression will be measured with the four-item Patient Health Questionnaire for Depression and Anxiety (PHQ-4).
Responses are scored as 0 ("not at all"), 1 ("several days"), 2 ("more than half the days"), or 3 ("nearly every day"), with the total score on this composite measure ranging from 0 to 12.
|
During the 7-day intervention period, measurements are conducted twice per day.
|
|
State stress
Time Frame: During the 7-day intervention period, measurements are conducted twice per day.
|
State stress will be measured using a single item adapted from the Psychological Stress Measure (PSM-9).
Participants will rate their state stress level on a sliding scale from 0 (not stressed at all) to 100 (very stressed), with higher scores indicating greater perceived stress.
|
During the 7-day intervention period, measurements are conducted twice per day.
|
|
State well-being
Time Frame: During the 7-day intervention period, measurements are conducted twice per day.
|
State well-being will be measured with one item inspired by the Well-Being Manifestations Measure Scale using a sliding scale ranging from 0 (not good at all) to 100 (very good).
|
During the 7-day intervention period, measurements are conducted twice per day.
|
|
State subjective happiness
Time Frame: During the 7-day intervention period, measurements are conducted twice per day.
|
State subjective happiness will be measured by the 2-item Subjective Happiness Scale with each item rated on a 7-point Likert scale from 1 (not a very happy person) to 7 (a very happy person).
|
During the 7-day intervention period, measurements are conducted twice per day.
|
|
State psychological flexibility
Time Frame: During the 7-day intervention period, measurements are conducted twice per day.
|
State psychological flexibility will be measured with Psy-Flex, a short self-report measure which covers all aspects of psychological flexibility.
Items are rated on a scale from 5 ("very often") to 1 ("very rarely") and then summed.
The score is then inter-preted such that higher scores represent higher psychological flexibility.
|
During the 7-day intervention period, measurements are conducted twice per day.
|
|
State psychological inflexibility
Time Frame: During the 7-day intervention period, measurements are conducted twice per day.
|
State psychological inflexibility will be measured with six item adapted from the Multidimensional psychological flexibility inventory using a sliding scale ranging from 1 (never true) to 6 (always true).
|
During the 7-day intervention period, measurements are conducted twice per day.
|
|
State suicide ideation
Time Frame: During the 7-day intervention period, measurements are conducted twice per day.
|
State suicide ideation will be assessed using a single item.
Participants will respond on a 0 to 4 scale, with higher scores indicating greater suicidal ideation.
|
During the 7-day intervention period, measurements are conducted twice per day.
|
|
Suicide ideation
Time Frame: Baseline (pre-intervention); Immediately after the intervention (1 week after baseline); 1-month follow-up (1 month after intervention)
|
Suicide ideation will be measured using the 5-item Beck Scale for Suicide Ideation (BSS-5).
Each item is rated on a three-point scale, with higher scores indicating greater suicidal ideation.
|
Baseline (pre-intervention); Immediately after the intervention (1 week after baseline); 1-month follow-up (1 month after intervention)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
April 15, 2025
Primary Completion (Estimated)
August 1, 2025
Study Completion (Estimated)
December 31, 2025
Study Registration Dates
First Submitted
February 20, 2025
First Submitted That Met QC Criteria
February 20, 2025
First Posted (Actual)
March 25, 2025
Study Record Updates
Last Update Posted (Actual)
March 25, 2025
Last Update Submitted That Met QC Criteria
March 6, 2025
Last Verified
February 1, 2025
More Information
Terms related to this study
Other Study ID Numbers
- HSEARS20250214003
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy Participants Study
-
Prothena Biosciences Ltd.Completed
-
UCB Biopharma SRLCompleted
-
AstraZenecaParexelCompletedHealthy Participants StudyGermany, United States, United Kingdom
-
UCB Biopharma SRLCompletedHealthy Study ParticipantsUnited Kingdom
-
Shanghai Argo Biopharmaceutical Co., Ltd.RecruitingHealthy Participants StudyChina
-
The Hong Kong Polytechnic UniversityNot yet recruiting
-
Shanghai Argo Biopharmaceutical Co., Ltd.Recruiting
-
Candid TherapeuticsActive, not recruitingHealthy Participants StudyAustralia
-
UCB BIOSCIENCES, Inc.CompletedHealthy Study ParticipantsUnited States
-
Bioagile Therapeutics Pvt. Ltd.Enrolling by invitationHealthy Participants StudyIndia
Clinical Trials on Mood monitoring
-
Lawrence UniversityCompletedSelf-Injurious Behavior | Depression, AnxietyUnited States
-
Northwell HealthNational Institute on Aging (NIA)CompletedType 2 DiabetesUnited States
-
University Hospital, GrenobleCommissariat A L'energie AtomiqueUnknown
-
Ohio State UniversityUniversity of Virginia; The University of Tennessee, KnoxvilleCompletedAlzheimer Disease | Caregiver Stress SyndromeUnited States
-
I.M. Sechenov First Moscow State Medical UniversityUnknownCognitive Dysfunction | Cerebral Small Vessel Diseases | Periodic Limb Movement DisorderRussian Federation
-
Mental Health Services in the Capital Region, DenmarkMaria Faurholt-Jepsen, MD, DMSc; The Mental Health Services in the Capital...RecruitingBipolar DisorderDenmark
-
University of MichiganCompletedDepression | Mood Disorders | Stress | Anxiety | Mental Health Wellness 1United States
-
Ilona MyllyniemiUniversity of CambridgeNot yet recruitingTracking Mood: The Effects of Daily Mood Tracking VAS on Alcohol Consumption in Adult Heavy DrinkersAlcohol Drinking | Alcohol Dependence | Alcohol Use Disorder | Alcohol Abuse | Alcohol Intoxication